CCDC18 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.865400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.227800E-01
Normal-vs-Stage2
4.988800E-01
Normal-vs-Stage3
4.056000E-01
Normal-vs-Stage4
4.312200E-01
Stage1-vs-Stage2
3.614600E-01
Stage1-vs-Stage3
8.311800E-01
Stage1-vs-Stage4
9.040000E-01
Stage2-vs-Stage3
3.513200E-01
Stage2-vs-Stage4
5.147800E-01
Stage3-vs-Stage4
7.152400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.943400E-01
Normal-vs-AfricanAmerican
2.810400E-01
Normal-vs-Asian
4.210000E-01
Caucasian-vs-AfricanAmerican
8.017800E-01
Caucasian-vs-Asian
4.503600E-02
AfricanAmerican-vs-Asian
6.605400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.621800E-01
Normal-vs-Female
5.184400E-01
Male-vs-Female
9.857900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.773600E-01
Normal-vs-Age(41-60Yrs)
5.254200E-01
Normal-vs-Age(61-80Yrs)
4.713600E-01
Normal-vs-Age(81-100Yrs)
4.880200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.7803000002844E-08
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.70870000004708E-06
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.359180E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.411020E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.409000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.626000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.970800E-01
Normal-vs-Daily Drinker
4.938200E-01
Normal-vs-Weekly Drinker
4.804000E-01
Normal-vs-Occasional Drinker
4.720400E-01
Normal-vs-Social Drinker
5.415600E-01
Non Drinker-vs-Daily Drinker
9.665400E-01
Non Drinker-vs-Weekly Drinker
8.237400E-01
Non Drinker-vs-Occasional Drinker
7.253000E-01
Non Drinker-vs-Social Drinker
5.750600E-01
Daily Drinker-vs-Weekly Drinker
8.380800E-01
Daily Drinker-vs-Occasional Drinker
7.249600E-01
Daily Drinker-vs-Social Drinker
4.928600E-01
Weekly Drinker-vs-Occasional Drinker
9.433200E-01
Weekly Drinker-vs-Social Drinker
4.569400E-01
Occasional Drinker-vs-Social Drinker
2.698800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.241600E-01
Normal-vs-Grade 2
8.377200E-01
Normal-vs-Grade 3
8.379800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.228300E-02
Grade 1-vs-Grade 3
6.045600E-02
Grade 1-vs-Grade 4
7.241600E-01
Grade 2-vs-Grade 3
9.987800E-01
Grade 2-vs-Grade 4
8.377200E-01
Grade 3-vs-Grade 4
8.379800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.969200E-01
Normal-vs-NonDiabetic
4.814800E-01
Diabetic-vs-NonDiabetic
7.141400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.113600E-01
Normal-vs-NoPancreatitis
4.712200E-01
Pancreatitis-vs-NoPancreatitis
4.152300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.828400E-01
Normal-vs-N1
4.945400E-01
N0-vs-N1
7.413000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.471800E-01
Normal-vs-TP53-NonMutant
4.401400E-01
TP53-Mutant-vs-TP53-NonMutant
2.754200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
